A Src-Tks5 Pathway Is Required for Neural Crest Cell Migration during Embryonic Development by Murphy, Danielle A. et al.
A Src-Tks5 Pathway Is Required for Neural Crest Cell
Migration during Embryonic Development
Danielle A. Murphy
1, Begon ˜a Diaz
1., Paul A. Bromann
1.¤a, Jeff H. Tsai
2, Yasuhiko Kawakami
3¤b, Jochen
Maurer
1, Rodney A. Stewart
4, Juan Carlos Izpisu ´a-Belmonte
2, Sara A. Courtneidge
1*
1Sanford-Burnham Medical Research Institute, La Jolla, California, United States of America, 2Department of Pharmacology, University of California San Diego, La Jolla,
California, United States of America, 3Salk Institute for Biological Studies, La Jolla, California, United States of America, 4Huntsman Cancer Institute, Salt Lake City, Utah,
United States of America
Abstract
In the adult organism, cell migration is required for physiological processes such as angiogenesis and immune surveillance,
as well as pathological events such as tumor metastasis. The adaptor protein and Src substrate Tks5 is necessary for cancer
cell migration through extracellular matrix in vitro and tumorigenicity in vivo. However, a role for Tks5 during embryonic
development, where cell migration is essential, has not been examined. We used morpholinos to reduce Tks5 expression in
zebrafish embryos, and observed developmental defects, most prominently in neural crest-derived tissues such as
craniofacial structures and pigmentation. The Tks5 morphant phenotype was rescued by expression of mammalian Tks5,
but not by a variant of Tks5 in which the Src phosphorylation sites have been mutated. We further evaluated the role of
Tks5 in neural crest cells and neural crest-derived tissues and found that loss of Tks5 impaired their ventral migration.
Inhibition of Src family kinases also led to abnormal ventral patterning of neural crest cells and their derivatives. We
confirmed that these effects were likely to be cell autonomous by shRNA-mediated knockdown of Tks5 in a murine neural
crest stem cell line. Tks5 was required for neural crest cell migration in vitro, and both Src and Tks5 were required for the
formation of actin-rich structures with similarity to podosomes. Additionally, we observed that neural crest cells formed Src-
Tks5-dependent cell protrusions in 3-D culture conditions and in vivo. These results reveal an important and novel role for
the Src-Tks5 pathway in neural crest cell migration during embryonic development. Furthermore, our data suggests that
this pathway regulates neural crest cell migration through the generation of actin-rich pro-migratory structures, implying
that similar mechanisms are used to control cell migration during embryogenesis and cancer metastasis.
Citation: Murphy DA, Diaz B, Bromann PA, Tsai JH, Kawakami Y, et al. (2011) A Src-Tks5 Pathway Is Required for Neural Crest Cell Migration during Embryonic
Development. PLoS ONE 6(7): e22499. doi:10.1371/journal.pone.0022499
Editor: Maddy Parsons, Kings College London, United Kingdom
Received April 24, 2011; Accepted June 27, 2011; Published July 25, 2011
Copyright:  2011 Murphy et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Cancer Institute of the National Institutes of Health (NIH) and the Mather’s Foundation. D.A.M. was supported
by training grant T32 CA121949 and the American Cancer Society North Texas Postdoctoral Fellowship, 2008, North Texans Creating Tomorrow’s Miracles. J.H.T.
was supported by training grant T32 CA121938. R.A.S. was supported by NIH # ROO-NSO5860i. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: courtneidge@sanfordburnham.org
. These authors contributed equally to this work.
¤a Current address: VTT, Technical Research Centre of Finland, Espoo, Finland
¤b Current address: Stem Cell Institute and Department of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, Minnesota, United
States of America
Introduction
Initiation of cell migration requires a change in cell shape to
promote a pro-migratory (or mesenchymal) phenotype, coordi-
nated by a change in actin dynamics driven by actin-associated
proteins, GTPases, kinases, and the actinomyosin cytoskeletal
system [1,2,3]. These changes enable the cell to establish contacts
with, and directionally migrate through, the extracellular matrix
(ECM) in response to environmental stimuli [2]. In the adult
organism, cell migration is restricted to cells that are required to
traverse extracellular matrices during processes such as wound
healing, angiogenesis, immune surveillance, and cancer metastasis.
Migration of normal cells is most prominently found during
embryogenesis where cells are required to move in 3-dimensional
space to pattern the embryo and generate organs and tissues.
During early development, migratory cells undergo epithelial to
mesenchymal transitions (EMT), which enable the generation of a
mesenchymal phenotype to promote cell migration [4]. This
occurs in gastrulation during convergence and extension [5] and
continues during neural crest emergence [4].
Neural crest cells are highly migratory, multipotent cells that
arise in the dorsal neural tube between the neural plate and non-
neural ectoderm (reviewed in [6]). These cells undergo EMT to
enable delamination from the neural tube and subsequent
migration to distant locations. Neural crest cells differentiate into
ectomesenchymal (bone and connective tissue) and non-ectome-
senchymal (neural and pigment cells) derivatives (reviewed in [7]).
TGFb induces migration of neural crest cells by upregulating
many transcription factors such as Foxd3, Sox10, Twist, Snail, and
Slug [8,9] and regulating attachment to the ECM [10]. It has
previously been shown that migrating neural crest cells form actin-
rich, dendritic-like protrusions, which probe their surroundings,
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22499and enable them to receive cues from neighboring neural crest
cells or the ECM to promote directional migration [11,12].
Interestingly, the change to a pro-migratory phenotype induced in
neural crest cells through EMT and the generation of dendritic-
like projections is similar to that used by invasive tumor cells
during metastasis.
One protein that has been found to regulate cancer cell invasion
is the Src substrate and adaptor protein, Tks5 (originally called
Fish) [13]. Tks5 has an amino-terminal phox homology (PX)
domain, five SH3 domains [13,14], and two Src phosphorylation
sites. Knockdown of Tks5 expression through RNA interference
results in loss of protease-dependent invasion of both Src-
transformed fibroblasts and human cancer cells [15,16,17]. Our
studies have also defined a role for Tks5 in the formation of
invadopodia, actin-rich membrane protrusions that coordinate cell
migration with pericellular proteolysis in vitro and tumor growth
in vivo [17,18]. Additionally, the phosphorylation of Tks5 by Src
regulates the actin cytoskeleton, through association with the
adaptor protein Nck, suggesting a mechanism by which Tks5-
dependent invadopodia regulate cell invasion [19]. Together,
these studies demonstrate that a Src-Tks5 pathway plays an
important role in tumor cell migration/invasion via invadopodia
formation. However, a role for this pathway in a physiological
context has not been described.
We examined a role for Tks5 during embryonic development by
using zebrafish, Danio rerio. Here we show that during embryonic
development, the Src-Tks5 pathway is required for the migration
of neural crest cells, a highly migratory, undifferentiated,
multipotent cell type. Additionally, this pathway appears to
regulate neural crest migration through the formation of pro-
migratory, actin-rich, protrusions in vivo, and in both 2D and 3D
culture in vitro, where these protrusions show podosomal features.
Results
Neural crest derivatives are affected by loss of Tks5
during embryonic development
Danio rerio contains a single copy of a gene (designated
SH3PXD2A) encoding a Tks5-like protein with 60% identity to
the murine and human Tks5-encoding genes (data not shown).
Using quantitative PCR and in situ hybridization on embryos at
various stages of development, we demonstrated that Tks5 was
expressed in early stages of developing embryos, and its expression
increased throughout development (Figure S1A). To assess the
effects of Tks5 loss on development, we microinjected one-cell
stage embryos with morpholinos (MO) designed to target Tks5
(Figure 1A). At 48 hours post fertilization (hpf), Tks5 MO-injected
embryos had smaller heads with small eyes, edema around the
heart, and overt delay in appearance of pigment cells in the tail
when compared to uninjected or 59-mismatch (MM) control
embryos (Figure 1B, S1B, S1C). Defects were also visible in the
developing lateral line and in touch responses (data not shown).
Figure 1. Tks5 is required for embryonic development in Danio rerio. (A) Schematic of Tks5 targeted morpholinos (MO) and the zebrafish
Tks5 gene. (B) The morphology of Tks5 morphants (T5.1 MO+p53 MO) at 48 hpf compared to controls (Uninjected, Control MO, p53 MO). Enlarged
images of the tail region show a reduction in posterior pigment cells (dashes outline tail in morphants). Scale bar represents 200 mm. (C) Tks5 MO
specificity was determined by injecting embryos with either tks5:GFP mRNA or tks5:GFP mRNA together with Tks5 MO, and analyzing GFP expression.
Two representative embryos from each injection are shown. (D) Quantification of murine Tks5 rescue of Tks5 morphant phenotypes. Embryos were
injected as indicated in Experimental Procedures. The total number of morphants (white bars) was compared to the total number of normal embryos
(black bars), and quantified as described in Materials and Methods (n=3).
doi:10.1371/journal.pone.0022499.g001
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injection with a p53 MO, which has been reported to rescue off-
target effects of some MOs [20] (Figure 1B). Two non-overlapping
translational Tks5 morpholinos (T5.1_ATG, T5.2_ATG, 3 ng)
caused similar abnormal morphological defects (Figure S1B, data
not shown). In addition, we observed the same morphological
defects with a splice-blocking MO targeted to the intron 2/exon 3-
splice donor/acceptor site of Tks5 (T5_sp, 5 ng) (data not shown).
Reduction in Tks5 expression caused by T5_sp MO was
confirmed by PCR (Figure S1D). Finally, we noted significantly
diminished GFP expression from a GFP-reporter construct fused
to the binding region for the Tks5_1 MO in embryos co-injected
with Tks5 MO (Figure 1C). These results demonstrate the
specificity of both the translational and splice-blocking morpho-
linos targeting Tks5, and that these Tks5 MOs can impair aspects
of post-gastrulation embryonic development. For subsequent
experiments, we used both T5_1 and T5_sp MO, using the
generic term Tks5 MO (T5 MO), for simplicity. Details of which
morpholino was used in each experiment can be found in
Materials and Methods.
To confirm that Tks5 MO-induced morphological defects could be
attributed to decreased Tks5 expression, we co-injected murine
T k s 5 m y cR N A( 3 0 0n g )w i t hT k s 5M O( 3n g ) .S e q u e n c ed i f f e r e n c e s
between the species means that the zebrafish Tks5-specific morpho-
linos would be unable to bind to murine Tks5 RNA, and would
therefore specifically silence endogenous zebrafish Tks5. Expression of
murineTks5phenotypically rescued the Tks5 morphants, as quantified
by counting the number of normal and morphant embryos within each
group (Figure 1D). Tks5 expression was confirmed by immunoblotting
for the myctag in lysates of Tks5myc co-injected embryos (Figure S1E).
These studies confirm that Tks5 MO-induced morphological defects
are specifically attributed to the loss of Tks5 expression and that Tks5 is
required for embryonic development.
Interestingly, the majority of defects observed in Tks5 morphants
are found in neural crest-derived tissues. For example; neural crest
cellsareresponsiblefortheseptationofthecardiacoutflowtractand
for aortic arch artery development in the heart, which could be the
cause of increased edema in Tks5 morphants, as well as in the
generation of craniofacial structures, pigmentation, and neuronal
lineages [21,22], which are abnormal in Tks5 morphants
(Figures 1B, S1B, S1C). We focused on two such tissues: pigment
cells (specifically melanophores), and the craniofacial cartilage.
Quantification of pigmented melanophores in the trunk region
above the yolk sac extension of control and Tks5 MO-injected
embryos at 48 hpf confirmed that Tks5 morphants had a significant
decrease in melanophore numbers (Figures 2A,B). Co-injection of
Tks5 MO with Tks5myc RNA rescued the decrease in pigmented
melanophorenumbers observed in the Tks5 morphants, confirming
that Tks5 was required for neural crest-derived pigment cells
(Figure 2C). To determinewhether Tks5 MO-injected embryos had
craniofacial defects, we stained uninjected, control MO-injected,
and Tks5 MO-injected embryos with Alcian blue and qualitatively
analyzed the cartilage structures formed. Tks5 morphants had
visible malformations in the ceratobranchials, palatoquadrate,
ethmoid plate, and Meckel’s cartilage (Figure 2D). The majority
of these defects were rescued by the co-injection of Tks5myc
mRNA, demonstrating that Tks5 is also required for neural crest-
derived craniofacial structures during embryonic development
(Figure 2E). Together, these results indicate a specific role of Tks5
in neural crest development and proper formation of its derivatives.
Neural crest migration in vivo
Many developmental diseases and syndromes that are associated
with craniofacial dysmorphology can be attributed to defects in
neural crest migration [23,24]. Additionally, abnormal neural crest
cell migration is responsible for deficiencies in pigment pattern
formation in the embryo [25,26]. Since we observed both of these
defects in Tks5 morphants, we investigated whether Tks5 was
required for neural crest cell migration in vivo. To ascertain this, we
first conducted whole-mount in situ hybridization on control and
Tks5 morphant embryos using neural crest specific probes (sox10,
crestin, mitf). At 26 hpf, there was a decrease in the number of neural
crest cells migrating dorso-ventrally in morphant embryos com-
pared to controls (Figure 3A). This result was confirmed by
quantification of sox10, crestin, and mitf positive cells migrating in the
trunk region (Figure 3B). Additionally, we noticed a decrease in
mitf-positive melanophore precursors at the posterior end of the
morphant embryos, potentially contributing to the lack of
melanophores in the tail region of Tks5 morphants (Figure 3A).
Concomitantly, we observed a similar, if not increased number of
pre-migratory, dorsally located, neural crest cells in morphant
embryos compared to controls (Figure 3A, dorsal staining),
suggesting that at this stage of development, interfering with Tks5
expression affected the migrationor numberofneural crest cells.To
investigate whether the decreased number of ventrally migrating
neural crest cells could be attributed to apoptosis, we stained both
control and Tks5 morphant Tg(sox10:RFP) embryos (which have
fluorescently labeled pre- and post-migratory neural crest cells [27])
with acridine orange. Tks5 morphants had an increased number of
apoptotic cells on the dorsal side compared to control (Figure 3C).
However, apoptotic staining did not co-localize with the majority of
RFP-labeled neural crest cells (Figure 3C). Further analysis revealed
minimal ventral migration of neural crest cells at the posterior end
of Tks5 morphants (Figure 3C, brackets), and these ventrally
migrated neural crest cells lacked extensive dendritic-like protru-
sions (Figure 3C, box). Together, these data suggest that abnormal
patterning of neural crest cells and their derivatives is most likely
attributed to migratory defects.
To look in more detail at the role of Tks5 in neural crest
migration, we used confocal time-lapse microscopy to visualize
Tg(sox10:RFP) embryos injected with either control or Tks5 MO.
At 30 hpf, RFP-labeled neural crest cells in control-injected
embryos could be seen migrating ventrally between the somites in
the trunk region [Figure 3D, Movie S1]. In contrast, RFP-labeled
neural crest cells in Tks5 morphants were present but predom-
inantly remained on the dorsal aspect of the embryo (Figure 3D,
Movie S2). Analysis of individual cells showed impaired motility
and/or directionality in morphant embryos that was not observed
in control embryos (Figure 3D, Movies S1, S2). In particular, there
was a decrease in neural crest cell velocity in Tks5 morphant
embryos compared to control (Figure 3E). This affect on neural
crest migration can be attributed to loss of Tks5 since time-lapse
imaging of Tg(sox10:RFP) embryos co-injected with both Tks5myc
and Tks5 MO exhibited similar neural crest migration patterns
and velocities as control embryos (Figure 3E, Movie S3).
Additionally, neural crest cells in morphant embryos appeared
to have a reduced number of cells elaborating protrusions during
their migration as compared to control cells, suggesting a role for
Tks5 in production of these protrusions during neural crest
migration (Figure 3D, asterisks). These data, combined with
whole-mount in situ analysis, demonstrate that Tks5 is required for
neural crest cell migration during embryonic development.
A Src-Tks5 pathway is required for NC cells and
NC-derived cells during embryonic development
Tks5 was first identified as a Src substrate [13], and its
phosphorylation by Src is required for tumor cell migration/
invasion in vitro [28]. Since we observed Tks5-dependent defects
Tks5, Src and the Neural Crest
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wanted to determine whether Src family kinases (SFKs) are also
necessary for migration of neural crest cell and their derivatives in
vivo. To determine this, we first treated zebrafish embryos with
SU6656 and PP2 (chemically distinct pharmacological inhibitors
of SFKs [29,30]) and examined their effects on neural crest cells
and neural crest-derived melanophores. Inhibitors were added
after gastrulation (between 8 and 15 hpf) to specifically study the
impact of SFKs on neural crest migration but circumvent the
requirement for the SFKs Fyn and Yes during gastrulation of
zebrafish [31,32]. Using RFP-labeled neural crest cells in
Tg(sox10:RFP) embryos, we found that embryos treated with
SU6656 at 8 hpf appeared to have a 50% decrease in the number
of ventrally migrating neural crest cells above the yolk sac
extension 24 hours post-treatment. It appeared as though these
cells remained primarily positioned on the dorsal side of the
embryo following treatment (Figure 4A). Concurrently, there were
fewer cells between somites in SU6656-treated embryos compared
to vehicle treated embryos (Figure 4A). We also observed a
decreased number of melanophores in the SU6656-treated
embryos and these cells had abnormal patterning (Figures 4B,C).
While the decreased number of melanophores may have been due
to alterations in cell survival or proliferation, the abnormal
patterning is likely due to migration defects, as previously stated
[26]. These data suggest that the activity of one or more SFKs are
required for neural crest cells and neural crest-derived cells during
Figure 2. Decreased Tks5 expression results in neural crest-derived defects. (A–B) Melanophores within the trunk region above the yolk sac
extension in control MO-injected and Tks5 MO-injected embryos were qualitatively (A) and quantitatively (B) analyzed. n=15 embryos and SEM is
shown by bar. p values obtained from Student’s t-test. ** denotes p,0.01. (C) Melanophores present in the dorsal, ventral, and lateral pigment lines
were quantified to determine degree of murine Tks5 rescue of the decreased pigmentation seen in morphants. Mean values (n=3) and SEM are
shown in graph. p values obtained from Student’s t-test. ** denotes p,0.01. (D) Alcian blue staining was performed on indicated embryos to identify
craniofacial structures (Meckel’s cartilage (mc), palatoquadrate (pq), ceratobranchials (ch), ethmoid plate (ep)). (*) denotes missing structures. (E)
Alcian blue staining was performed on indicated embryos to determine if murine Tks5 could rescue craniofacial defects seen in morphants. Structures
were identified as in (D). (*) denotes missing structures.
doi:10.1371/journal.pone.0022499.g002
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and are likely to play an important role in regulating their
migration.
Both Src and Tks5 affect neural crest cells and neural crest-derived
cells similarly during development. Yet the presence of a Src-Tks5
pathway has yet to be observed in vivo. We therefore wanted to
Figure 3. Neural crest migration in vivo requires Tks5. (A–B) Whole mount in situ hybridizations to detect neural crest cells were performed on
control (Tks5 MM) and Tks5 morphant (Tks5 MO) embryos at 26 hpf. (A) Neural crest specific riboprobes against foxd3, sox10, and crestin (ctn) were
used. Bars indicate anterior-posterior area of migrating cells. (*) indicates an increase in pre-migratory cells compared to controls (B) The numbero f
cells migrating into the trunk region was quantified as described in Materials and Methods. Mean values (n=18) and SEM were shown in graph. p
values obtained from Student’s t-test. ** denotes p,0.01. (C) Control (T5 MM) and Tks5 morphant (T5 MO) Tg(sox10:RFP) embryos (28 hpf) were
incubated with acridine orange as a marker for apoptosis and imaged by fluorescence microscopy. NC=neural crest cells, AO=acridine orange,
brackets designate similar regions of migrating NC cells, and boxes label similarly positioned individual NC cells in the control and morphant embryos
(enlarged in bottom left corner of top panel). (D) Control (T5 MM) and Tks5 morphant (T5 MO) Tg(sox10:RFP) embryos (30 hpf) were analyzed for
neural crest migration by confocal time-lapse microscopy for 1.5 hours as described in Materials and Methods. Arrows follow ventral cell migration of
an individual cell over the duration. *=protrusions emanating from neural crest cells (D=dorsal, V=ventral, A=anterior, P=posterior). (E) The
average velocities of individual neural crest (NC) cells for control (T5 MM)-, Tks5 MO-injected, Tks5myc RNA and Tks5 MO co-injected, or Tks5FFmyc
RNA and Tks5 MO co-injected Tg(sox10:RFP) embryos were quantified as detailed in Materials and Methods. Mean values (n=10) and SEM are shown.
p values obtained from Student’s t-test.** denotes p,0.01.
doi:10.1371/journal.pone.0022499.g003
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in zebrafish embryos. To conduct these studies, we tested a murine
Tks5 construct mutated in the two Src phosphorylation sites, Y557
and Y619 [known as Tks5FFmyc], for its ability to rescue the
developmental defects caused by decreased Tks5 expression
(Figures 4D,E). Tks5FFmyc/Tks5MO co-injected embryos had the
same, or perhaps even an increased frequency of pigmentation,
craniofacial, heart, and locomotion defects when compared to
embryos injected with Tks5 MO alone (Figures 4D,E, S2). This was
in direct contrast to wild-type Tks5myc co-injection with Tks5 MO,
which rescued the embryonic defects as previously demonstrated
(Figures 4D,E, S2). Additionally, neural crest cells of Tks5FF co-
injected embryos had decreased velocity and fewer cell protrusions,
similar to, and perhaps more severe, than that observed in Tks5
morphants (Figure 3E, Movie S4). Together with our previous
studies, these results demonstrate a requirement for both SFKs and
Tks5 in neural crest cells during the segmentation-pharyngeal period
of the developing embryo, and that this pathway involves, at least in
part, Src-mediated phosphorylation of Tks5.
Tks5 regulates neural crest stem cell migration and
podosome formation in vitro
Extracellular cues have been shown to play a role in cell migration
[33]. To investigate whether the migration defects we see in Tks5
morphant embryos were cell autonomous to neural crest cells, we
investigated whether Tks5 was required for neural crestcellmigration
in vitro by using a murine neural crest stem cell line, JOMA1.3 [34].
Since TGFb is required for the initiation of neural crest
differentiation and promotes migration [10], we placed control and
Tks5 knockdown JOMA1.3 cells in transwell migration chambers
containing TGFb. We observed a two-fold reduction in migration of
Tks5 knockdown cells through transwell chambers towards media
containing TGFb compared to control cells (Figures 5A–B). These
data indicate that Tks5 is required for neural crest cell migration,
most likely in a cell autonomous manner.
Cell migration is dependent on a shift from an adhesive to a
pro-migratory phenotype, and can involve the formation of one or
more actin-rich cellular protrusions (lamellipodia, filopodia, focal
adhesions, podosomes, and invadopodia), which promote direc-
tional cell movement and attachment to the ECM. To investigate
whether neural crest cells formed actin-based protrusions, we co-
immunostained for cortactin and F-actin (using phalloidin). Under
normal culture conditions, JOMA1.3 cells formed only actin stress
fibers and Tks5 is cytoplasmic (Figure S3A). However, addition of
either PMA or TGFb, which are known stimulators of cell
migration [35,36], resulted in the formation of actin-rich puncta
near the leading edge of the cells (Figures 5C, S3A, S3B). These
actin-rich protrusions also contained Tks5 and the actin associated
Figure 4. Neural crest derivatives require a Src-Tks5-dependent pathway in vivo. (A) Tg(sox10:RFP) embryos (8 hpf) were treated with
either vehicle (DMSO) or SU6656 for 24 hours and imaged by confocal microscopy to detect neural crest cells. (D=dorsal, V=ventral). Brackets
indicate the position of the somites. Scale bar represents 50 mm. (B–C) Embryos at 15 hpf were treated as indicated for 24 hours and analyzed for
pigmentation defects. (B) Embryos where treatment was initiated at 15 hpf were examined for melanophore patterning in the trunk region above the
yolk sac extension. (D=dorsal, V=ventral, A=anterior, P=posterior) (C) The total number of melanophores present in the dorsal and ventral pigment
lines was counted for embryos within each group as described in Materials and Methods. Mean values (n=3) and SEM were shown in graph. **
denotes p,0.01 for vehicle treated vs. SFK treated comparison. (D–E) Embryos were injected as indicated and qualitatively analyzed for defects
described previously. Morpholino and RNA concentrations detailed in Materials and Methods. (E) Morphants were identified as described in Figure 1D
and embryos within each group were quantified (white=morphants, black=normal).
doi:10.1371/journal.pone.0022499.g004
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PLoS ONE | www.plosone.org 6 July 2011 | Volume 6 | Issue 7 | e22499Figure 5. Migration of, and podosome formation in, neural crest stem cells requires Tks5. (A–B) Control (Scr) and Tks5 knockdown (shT5.1
and shT5.2) JOMA1.3 cells were exposed to a TGFb gradient using the transwell migration assay. The number of migrating cells was qualitatively
analyzed in each group (A) and quantified as described in Materials and Methods (B). Mean values (n=3) and SEM were shown in graph. ** denotes
p,0.01. (C) TGFb-stimulated (25 ng/ml) JOMA1.3 cells were immunostained for F-actin (using phalloidin) and the podosome markers cortactin, Arp2/
3, and Tks5 to identify formation of podosomes (arrows). In all cases, scale bars represent 10 mm and white arrows point to clusters of podosomes. (D)
Confocal microscopy of TGFb-stimulated JOMA1.3 cells co-stained for F-actin (using phalloidin) and cortactin. (E) JOMA 1.3 cells were treated with
TGF-b and stained for SMAD2 by immunofluorescence to confirm activation of TGF-b-dependent pathways. (F–G) Vehicle (DMSO) or SFK inhibitors
Tks5, Src and the Neural Crest
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stimulated F-actin and cortactin positive puncta were co-localized
in the ventral membrane as demonstrated by confocal microscopy
(Figure 5D). These properties - the presence of F-actin, cortactin,
Tks5 and Arp2/3, and ventral location – are used to define
podosomes in other cell types. We therefore conclude that, upon
cytokine stimulation, neural crest stem cells form podosomes in
vitro. Finally, the induction of TGFb responses in JOMA1.3 cells
was confirmed by immunofluorescence staining for the TGFb-
regulated expression of SMAD2 in the nucleus of stimulated cells
(Figure 5E).
Since Src and Tks5 are required for the formation of
invadopodia in cancer cells, we wanted to determine whether
these podosome structures in neural crest stem cells were also
dependent on SFK activity and Tks5. SFK inhibitors prevented
the formation of both PMA and TGFb-induced podosomes in
JOMA1.3 cells (Figures 5F,G, S3C, S3D). To explore whether the
Src substrate Tks5 was also required, we inhibited Tks5 expression
in JOMA1.3 cells via lentiviral-mediated shRNA knockdown, and
then stimulated with TGFb. Two independent, Tks5-specific
shRNAs decreased TGFb-induced podosome formation com-
pared to control cells, and profoundly altered the cytoskeletal
structure of the cells, resulting in a flattened cell appearance with
decreased cortactin staining (Figures 5H–J). Similar results were
observed following PMA stimulation (Figures S3E, S3F). Togeth-
er, these data demonstrate that both Src and Tks5 are required for
TGFb-induced podosome formation in neural crest stem cells.
To investigate whether podosome-like structures are formed
under more physiologically relevant conditions, we cultured
JOMA1.3 in a three-dimensional (3D) collagen matrix model.
We observed extensive actin-rich protrusions in control cells, but
fewer and shorter protrusions in Tks5 knockdown cells (Figure 6A).
Furthermore, there is a striking similarity between the Tks5-
dependent protrusions formed in a 3D matrix in vitro and Tks5-
and Src-dependent dendritic-like extensions emanating from the
cell body of neural crest cells and derivatives in vivo (Figures 3D,
6B, 6C). We measured these extensions in control and Tks5
morphant embryos and observed a significant decrease in their
length with no change in their width (Figure 6C). The width of
these dendritic-like protrusions is similar to the measured width of
podosomes. More importantly, the average length of these
structures (10–20 mm) appeared to be more similar to podosomes
(.10 mm) than those of any other pro-migratory structures such as
filopodia (,10 mm). These studies suggest that a Src-Tks5-
dependent pathway regulates neural crest cell migration in vivo,
by regulating the ability of neural crest cells to form dendritic-like
cell protrusions with similarities to podosomes.
Discussion
We manipulated the expression of Tks5 in zebrafish using
morpholino technology. Our studies revealed striking phenotypic
differences between control and Tks5 morphants, implicating a
role for Tks5 in multiple cell lineages during development. The
majority of the defects in Tks5 morphants were in neural crest-
derived organs and tissues including the heart, craniofacial
structures, the lateral line and pigmentation, suggesting that
Tks5 is required for neural crest cell function during embryonic
development. While we cannot rule out possible minor gastrula-
tion defects in Tks5 morphants, we believe the phenotype is not
solely due to a gastrulation defect, since we observed normal
extension of the embryo body and no major reduction in pre-
migratory neural crest cells at early stages of development.
Furthermore, we demonstrate a role for a Src-Tks5 pathway in
development, and the addition of SFK inhibitors post-gastrulation
also blocked dorsal-ventral distribution of neural crest cells in the
trunk region.
What is the nature of the neural crest defect in Tks5 morphant
zebrafish? We have provided several lines of evidence, both in vitro
and in vivo, that migration of neural crest and neural crest-derived
cells is impaired in the absence of Tks5. Furthermore, our in vitro
studies support a cell autonomous requirement for Tks5 in neural
crest cell migration in vivo. It is possible that loss of Tks5 also affects
neuralcrestcell proliferation ordifferentiation.However,webelieve
that any impact of Tks5 on differentiation is likely to be relatively
minor. For instance, in situ hybridization studies using markers for
neural crest cells (foxd3 and sox10) demonstrated that there were
similar, if not increased, numbers of neural crest cells on the dorsal
side of Tks5 morphants at 26 hpf. Furthermore, while markers of
neural crest-derived tissues, such as mitf, appeared to be reduced at
26 hpf, Tks5 morphant embryos still had abnormal posterior and
ventral migration of mitf-positive cells, suggesting that those cells
that have differentiated fail to migrate appropriately in the absence
of Tks5. Additionally, neural crest and neural crest-derived cells
were present on the dorsal aspect of morphant zebrafish, as well as
zebrafish treated with SFK inhibitors. Therefore, while a potential
role for Tks5 in differentiation deserves further study, we propose
that the primary role of Tks5 is to participate in the directional
migration of developmental cell types.
Neural crest progenitors are multipotent cells that are highly
migratory during embryonic development, but the actin-cytoskeletal
dynamics regulating their migration is relatively unexplored. Here
we demonstrate that TGFb stimulation of neural crest cells in vitro
causes the formation of Src and Tks5-dependent podosomes, and
that Tks5 and Src are required for neural crest cell migration. In
vivo, migrating neural crest cells have been shown to display
dendritic-like protrusions with a concentration of actin at their tips,
which are dependent on Rho-kinase and myosin II for their
formation [37]. Furthermore, Src activity is increased 2–7 fold in the
dendrites of neural crest-derived melanocytes in vitro [38,39]. We
now find that a Src-Tks5-dependent pathway is required for both
neural crest cell migration and formation of dendritic-like protru-
sions in neural crest cells in vivo and in vitro. Might these dendritic-
like protrusions be related to podosomes? Podosomes were first
discovered by their ability to mediate cell attachment to the ECM
[40]. The directional migration of neural crest cells is dependent on
cell-contactandtheirattachmenttothe ECM[10,11,12].Therefore,
it is intriguing to think that neural crest cell podosomes might
(SU6656 and PP2) were added to JOMA1.3 cells prior to TGF-b stimulation followed by analysis of podosome formation by immunostaining for F-actin
(phalloidin) and cortactin (arrows). (G) The total number of cells with podosomes was quantified for each treatment group and analyzed as fold
change of cells with podosomes compared to untreated cells. Fold change of cells was compared to vehicle treated cells. Mean values (n=3) and SEM
were shown in graph. ** denotes p,0.01 for vehicle vs. SFK treated comparison. (H–J) Tks5 was knocked-down in JOMA1.3 cells by two independent
shRNA constructs [shTks5.1 (shT5.1), shTks5.2 (shT5.2)]. (H) Untreated, control (scrambled shRNA), and Tks5 knockdown cells were stimulated with
TGFb for 5 hours and stained for F-actin and cortactin to identify podosomes. (I) The percentage of cells with podosomes was quantified (as
described in Materials and Methods. Mean values (n=3) and SEM are shown. p values obtained from Student’s t-test. ** denotes p,0.01. (J) Tks5
knockdown was confirmed by immunoblot analysis for Tks5 using whole cell lysates and anti-Tks5 antibody. Protein levels were normalized to
tubulin.
doi:10.1371/journal.pone.0022499.g005
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possibility, since there are structural and functional similarities
betweenthe Src-Tks5-dependent podosomesthatwe observed in2D
culture, the elongated actin-rich extensions observed in 3D culture,
andthedendritic-likeprotrusionspreviouslydescribedinneuralcrest
cells in vivo and also visualized in our study. Further analysis is
clearly warranted to fully characterize and compare these protrusive
structures. Thepodosomes and invadopodia found inadultcelltypes
are often endowed with the ability to degrade ECM. Neural crest
cells also have the capacity to degrade ECM, and they produce
proteolytic enzymes, including plasminogen activator and metallo-
proteinases [9,41,42]. Additionally, electron microscopy has re-
vealed that the basal lamina around the neural tube is incomplete
during neural crest cell emigration and migration [43,44]. Since the
ECM plays an important role during development [45], with
alterations in expression of collagen and the ECM proteases
membrane-type 1 matrix metalloproteinase, ADAM19, and AD-
AM13 affecting gastrulation, neural crest cell differentiation, and
migration [46,47,48,49,50,51], it will be important to determine if
the dendritic-like protrusions are involved in ECM degradation.
We recently published that mutation of the gene encoding Tks4,
which is a family member of Tks5, is a cause of the human
developmental disorder, Frank-Ter Haar Syndrome (FTHS), which
is characterized by craniofacial and other skeletal abnormalities, as
well as eye and heart defects [52]. Tks4, like Tks5, is required for
invasiveness of Src-transformed cells [53], but the molecular basis of
its role in FTHS is not known. The model system we describe here
can be used to further dissect the roles and regulation of podosome/
invadopodia-associated proteins such as Tks4 and Tks5 during
embryonic development, as well as to study the genes involved in
other developmental diseases that can be attributed to deficiencies
in neural crest cell migration.
Materials and Methods
Ethics statement
AllinvivostudieswerereviewedandapprovedbyanInstitutional
Animal Care and Use Committee (IACUC), and conducted in
accordance with their guidelines. The Institutional Animal Care
and Use Committee at the Salk Institute for Biological Studies
approved protocol #09-029, held by Dr. Juan Carlos Izpisua-
Belmonte. The Institutional Animal Care and Use Committee at
the Sanford Burnham Medical Research Institute approved the
protocol AUF #09-033, which is held by Dr. Sara A. Courtneidge.
Materials
All morpholinos (MO) were designed by and obtained from
GeneTools. Translational Tks5 MOs were:
T5.1 59 ACTGCATTGTGAAAACGGAGG-
CTTC 39
T5.2 59 TTAGTGGTCAGAATAAACGGA-
CAGG 39
Tks5 splice (T5_sp) 59 TGCATCTGTGGGACGACACAA-
GAAA 39
p53 59 GCGCCATTGCTTTGCAAGAAT-
TG 39
Tks5.1 MO was used in Figures 3, 4 and S2. Both Tks5.1 MO
and Tks5_sp MO were used in Figures 1, 2 and S1. p53 MO was
used at 4 ng. Tks5.1 MO and Tks5.2 MOs were used at 3.5 ng.
Tks5_sp MO was used at 5 ng. pSGT-Tks5myc and pSGT-
Tks5FFmyc plasmids were generated by I. Pass and F. Wen. A
Tks5_1MO_GFP reporter construct was created through design-
ing primers targeting 20 bp of Tks5_1 ATG MO and EGFP (59 -
GCC TCC GTT TTC ACA ATG CAG AGC AAG -39) and (59-
Figure 6. Src- and Tks5-dependent neural crest cell dendritic-
like protrusions in 3-D culture and in vivo. (A) Control (scrambled)
and Tks5 knocked-down (shT5.2) JOMA1.3 cells were placed in a three-
dimensional collagen matrix and cultured for six days. Cells embedded
in the collagen matrix were stained for F-actin (phalloidin) and analyzed
for differences in cell structure (406). (B) Neural crest cell and neural
crest-derived cell protrusions were qualitatively examined by either
enlarging images of neural crest cells in Tg(sox10:RFP) embryos
obtained in 4A (left panels) or imaging melanophores in vehicle or
SU6656 treated embryos at a higher magnification (236) (right panels).
(C) Control (Tks5 MM injected) and Tks5 morphant Tg(foxd3:GFP)
embryos (30 hpf) were fixed and imaged by confocal microscopy. The
width and length of protrusions was measured by Volocity software.
Mean values (n=20) and SEM are shown. p values obtained from
Student’s t-test. ** denotes p,0.01. (D=dorsal, V=ventral, A=anterior,
P=posterior).
doi:10.1371/journal.pone.0022499.g006
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was placed into pCR2.1 TOPO (Invitrogen) and subcloned into
pCS2 plasmid for RNA generation. tks5:GFP mRNA was
generated using mMessage Machine SP6 kit (Ambion). tks5:GFP
mRNA was injected at 300 ng/ml. SU6656 was synthesized by Dr.
Greg Roth (SBMRI) and PP2 was obtained from EMD/
Calbiochem. Antibodies used include: actin (MP Biomedicals),
tubulin (Sigma), Smad2 and Hsp90 (Cell Signaling), phosphotyr-
osine (BD Transduction), and cortactin, Arp2/3, Tks5 and myc
clone 4A6 (all from Millipore). Alexa-488 anti-mouse, Alexa-488
anti-rabbit, Alexa-568 phalloidin and Hoechst were from Invitro-
gen. Vectashield (Vector Labs) was used as mounting medium for
all in vitro assays.
Animals
Wild-type (AB), Tg(foxd3:GFP), Tg(sox10:RFP), and Tg(mlc2A:GFP)
zebrafish strains [27,54] were maintained at 28.5uC by standard
methods [55]. Staging was by morphological criteria [56]. MOs were
dissolved in Danieau’s buffer and injected at 2–5 ng/ml into the yolk of
one-cell stage embryos; the optimal concentration was determined by
dose response titrations. Embryos were either grown in 1-phenyl 2-
thiourea (PTU) egg water or bleached with 0.3% hydrogen peroxide
prior to staining. Fixed embryos were placed in 80% glycerol, while live
embryos were placed in 1% agarose for imaging purposes.
PCR analysis
To analyze Tks5 expression in Tks5 morphants injected with
Tks5_sp, primers were designed to the Intron2/Exon3 region of
Tks5 (59-CCTTCATGCAGATACTCGAC-39) and (59CACG-
TCTCTTACATGACTTCG-39) and RT-PCR was performed on
cDNA obtained from 24 hpf embryos (50 each condition).
Zebrafish Tks5 expression was analyzed by quantitative PCR
using primers specific to the 59 region of Tks5 (59-TAAAAGTG-
GTGGATGTGGAG-39). Samples were normalized to cyclophilin
(59-GTATCTCAGCATCAGGTTCG-39) and fold increase was
compared to expression in 4-cell stage embryos.
Quantitative Analysis of Morphant Embryos
The eyes of control and Tks5 morphant embryos were
examined by measuring the length and width of each embryo’s
eye (n.10/condition). The volume of the eye was calculated using
the formula for a spheroid: [0.52*(width)
2(length)]. Cardiac defects
were examined using Tg(mlc2A:GFP) embryos that were either
injected with control or Tks5 MO. Embryos (30hpf) were
examined by fluorescence microscopy for their ability to induce
heart looping during development (n.20/condition).
Pigmentation analysis, whole-mount in situ
hybridization, and staining in vivo
Control and Tks5 morphant embryos (48 hpf) were imaged by
bright field microscopy to quantify melanophores in the trunk
region over the yolk sac extension and analyzed as percentage of
melanophore coverage by Image J software (n=15/condition).
For rescue experiments, the total number of melanophores in the
ventral, dorsal, and lateral pigment lines of embryos was counted
(n=5 per condition). Embryos at 5 dpf were stained with Alcian
blue as described [57] and analyzed for the presence of
craniofacial structures. Neural crest specific RNA probes (foxd3,
sox10, crestin, and mitf) were as described [57]. Migratory neural
crest cells were identified as cells staining positive for sox10, crestin,
or mitf in the trunk region between the dorsal side and yolk sac
extension (between somites 5–18) of 25 hpf embryos. The total
number of migrating cells was quantified for each probe (n=6 per
condition). Acridine orange (5 ug/ml, Sigma) was added to the
water of control (T5 MM) and Tks5 morphant (T5 MO)
Tg(sox10:RFP) embryos (28 hpf) for 1 hour followed by three
washes in E3 medium. Anesthetized embryos were then placed in
80% glycerol and imaged by fluorescence microscopy.
Rescue and SFK studies in vivo
Murine Tks5myc and Tks5FFmyc RNA were generated by
transcribing linearized pSGT-Tks5myc and pSGT-Tks5FFmyc
with mMessage Machine T7Ultra kit (Ambion). Compared to the
zebrafish Tks5 MO sequence, murine Tks5myc and Tks5FFmyc
RNA is homologous in only four out of 25 base pairs. Co-injection
studies used 300 ng/ml Tks5myc or 500 ng/ml Tks5FFmyc with
3.5 ng Tks5 MO. Optimal concentrations were determined
following dose response titrations. We characterize Tks5 mor-
phants as possessing a decrease in pigmentation, more rounded
heads, and smaller eyes. To quantify the number of morphants,
100 embryos per condition were quantified for normal or
morphant phenotypes for each experiment. For rescue studies,
lysates were generated from 75 embryos per condition at 24 hpf
using NP40 lysis buffer. These were immunoprecipitated with
anti-Myc antibody followed by SDS-PAGE immunoblot analysis
for Tks5. Protein levels were normalized to Hsp90 or actin as
indicated.
For SFK studies, SU6656 or PP2 were added to 0.5 ml egg
water containing 1% DMSO at concentrations of 3 mM and
15 mM, respectively. These were added to wells of a 12-well plate
containing 15 embryos (8 hpf or 15 hpf as indicated) per well and
incubated at 28uC for 24 hours. Melanophores were quantified by
counting the number in the ventral, dorsal, lateral pigment lines
(10 embryos per treatment). Confocal epifluorescence microscopy
was used to determine the localization and patterning of RFP-
labeled neural crest cells following SU6656 treatment.
Neural crest cells
JOMA1.3 cells are described in [34]. Phorbol-12-myristate-13-
acetate (PMA) was added at 25 ng/ml for 30 minutes prior to 4%
paraformaldehyde fixation. TGFb was added at 25 ng/ml for
5 hours prior to 4% paraformaldehyde fixation. Podosomes were
identified through immunofluorescence co-staining using Alexa-
568 phalloidin (1:500) and either cortactin (1:500), Arp2/3
(1:500), or Tks5 (1:500). Both Alexa-488 anti-mouse and anti-
rabbit secondary antibodies were used at 1:2000. Podosome
positive cells were defined as containing at least 10 positively co-
stained puncta. Percentage of cells with podosomes was obtained
by counting twelve fields for each condition. Localization of
Smad2 was identified through immunofluorescence staining of
Smad2 (1:250).
Tks5 and SFK studies in vitro
JOMA1.3 cells were treated with either vehicle (0.1% DMSO)
or SFK inhibitors at concentrations of 2 mM (SU6656) or 10 mM
(PP2) overnight prior to PMA or TGFb stimulation and analyzed
for podosome formation by immunofluorescence as previously
described. Due to the variation experienced by addition of
inhibitors, percentage of cells forming podosomes is normalized to
vehicle for all Src inhibitor studies and analyzed as fold change in
cells forming podosomes. Using similar concentration of lentivirus
as control shRNA, Tks5 expression was reduced in JOMA1.3 by
lentiviral shRNA vectors (shT5.1 and shT5.2). Control and Tks5
knockdown cells were treated with either PMA or TGFb and
analyzed for podosome formation. Tks5 knockdown was con-
firmed by obtaining protein using lysis buffer containing (50 mM
Tris pH 8.0, 150 mM NaCl, 1% Tx-100, 1 mM NaF, 100 mM
Tks5, Src and the Neural Crest
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and probing with anti-Tks5 and anti-tubulin antibodies.
Cell migration in vitro and in vivo
Untreated or JOMA1.3 cells were infected with similar
concentrations of lentivirus expressing either control (scrambled)
or Tks5 knock-down (shTks5.1 or shTks5.2) and plated at 7.5610
4
density in transwell migration assays in the presence of TGF-b
(25 ng/ml). Chamber wells were coated with a thin layer of
fibronectin (0.2 mg/ml, Sigma). Five fields per condition were
captured at 106(Spot RT Acquisition and Processing Software).
Area of cell coverage was quantified by Image J software.
Measurements were normalized to control cells. Tg(sox10:RFP)
embryos were injected with Tks5-mismatch MO, Tks5 MO, or co-
injected with Tks5 MO and murine Tks5 RNA or murine Tks5FF
RNA and imaged at 30 hpf by time-lapse laser confocal
microscopy. Images were captured every ten minutes for
1.5 hours. Individual neural crest cells from the embryos described
above (10 embryos/condition; 2 embryos/condition) were tracked
using Volocity software by marking the location of the cell body in
each single image captured for the duration of the 1.5 hours. This
enabled the calculation of the velocity of each individual cell/
condition using the software.
Imaging neural crest cells in 3D in vitro and in vivo
Control (scrambled) or Tks5 knocked-down (shT5.2) JOMA1.3
cells were mixed with native collagen I (from BD) at 2 mg/ml final
concentration, and plated in 8-chamber glass slides (BD Falcon) at
a density of 5000 cells per chamber. Cells were cultured for 7 days
and processed for fluorescence microscopy. Tg(foxd3:GFP) embry-
os were injected with either Tks5-mismatch MO or Tks5 MO,
fixed at 30 hpf, and imaged by confocal microscopy. The length
and width of neural crest cell protrusions were measured by
Volocity software (10 cells were measured in two different embryos
per condition).
Image acquisition
All cells for podosome formation assays in vitro were imaged
with a Zeiss Axioplan2 microscope and captured using an
AxioCam HRm camera. JOMA1.3 were imaged at 606
magnification for identification of podosomes. Images were
obtained through use of AxioVision 4.8. Zebrafish embryos were
imaged using a Nikon AZ100 inverted microscope attached to a
Retiga 2000R camera equipped with NIS Elements v.3 software
(Nikon). Melanophore images in Figure 6 were collected using a
Leica MZ16F scope attached to a Leica DFC300FX camera and
acquired with Image-Pro Plus software. Confocal images were
obtained using an Olympus Fluoview FV100 confocal microscope
at 30uC and analyzed using FV10-ASW (Olympus) or Volocity
software (Perkin Elmer). All images were processed using Image J
software.
Statistical analysis
All statistical analyses used the student’s t-test, except for
Figures 5B, 5G, S3D, which used Wilcoxon signed rank test.
Supporting Information
Figure S1 Tks5 is required for embryonic development
in Danio rerio. (A) Tks5 expression levels were examined
throughout embryonic development in zebrafish by quantitative
PCR. Levels were normalized to cyclophilin and fold increase was
compared to 4-cell embryonic stage (set at 1). (B) The eye volume
(mm
3) of control (T5 MM) and Tks5 morphants (T5.1 MO and
T5_sp) at 48 hpf was measured as detailed in the Materials and
Methods section. Mean values (n=12 and n=17, respectively)
and SEM are shown. p values obtained from Student’s t-test.
** denotes p,0.01. (C) Tg (mlc2:GFP) embryos (30hpf) uninjected
or injected with either control (T5 MM) or Tks5 morpholinos
(T5.1 MO and T5_sp) were examined for the ability to induce
heart looping by fluorescence microscopy. Embryos in each group
were quantified for the presence of a linear or looped heart. (D)
RT-PCR analysis using exon 3 specific primers of uninjected and
Tks5_sp MO-injected embryos at 24 hpf. (E) Lysates were
obtained from indicated embryos at 24 hpf and immunoprecip-
itated with anti-Myc antibody followed by immunoblotting for
Tks5. The blot was re-probed with anti-Hsp90 antibody for
loading controls.
(TIF)
Figure S2 Src phosphorylation of Tks5 affects neural
crest-derived cells. Lysates were obtained from indicated
embryos (24 hpf) as described in Experimental Procedures.
Tks5myc and Tks5FFmyc expression was detected by immuno-
precipitation for Myc and immunoblotting for Tks5. Loading was
normalized to actin.
(TIF)
Figure S3 Neural crest stem cells form podosomes. (A)
JOMA1.3 cells were stained for F-actin (phalloidin) and either
cortactin or Tks5 in the presence and absence of PMA (25 ng/ml)
to identify formation of podosomes (arrow). (B) PMA-stimulated
(25 ng/ml) JOMA1.3 cells were immunostained for F-actin (using
phalloidin) and the podosome markers cortactin, Arp2/3, and
Tks5. (C–D) Vehicle (DMSO) or SFK inhibitors (SU6656 and
PP2) were added to JOMA1.3 cells prior to PMA stimulation. (C)
Analysis of podosome formation was conducted by immunostain-
ing for F-actin (phalloidin) and cortactin (arrows). (D) The total
number of cells with podosomes was quantified for each treatment
group and analyzed as fold change of cells with podosomes
compared to untreated cells. Mean values (n=3) and SEM were
shown in graph. p values obtained from Student’s t-test. * denotes
p,0.05 for untreated vs. SFK treated comparison; ** denotes
p,0.01 for untreated vs. SFK treated comparison. (E–F) PMA-
treated control (uninfected and scrambled shRNA) and Tks5
knockdown (shT5.1, and shT5.2) cells were stained for F-actin
(phalloidin) and cortactin to identify formation of podosomes. (F)
Percentage of cells possessing podosomes was calculated as
previously described. Mean values (n=3) and SEM are shown
in graph. ** denotes p,0.01 for scrambled versus shT5.1 and
shT5.2. p values obtained from Student’s t-test. In all cases, the
white arrows point to clusters of podosomes.
(TIF)
Movie S1 Neural crest cell migration in control MO-
injected Tg(sox10:RFP) embryos at 30 hpf. Z-projected
time-lapse images from laser confocal microscopy (FV-1000,
Olympus) of control MO-injected Tg(sox10:RFP) embryos at 30
hpf for 1.5 hours (1 frame/10 min) showed ventral migration of
neural crest cells between somites towards the yolk sac extension.
Also observed was the generation of cell protrusions emanating
from the neural crest cells. Scale bars represent 30 mm. See
Figure 3 for still images and quantification of average neural crest
cell velocity.
(AVI)
Movie S2 Reduced neural crest cell migration in Tks5
MO-injected Tg(sox10:RFP) embryos at 30 hpf. Z-
projected time-lapse images from laser confocal microscopy (FV-
1000, Olympus) of Tks5 MO-injected Tg(sox10:RFP) embryos at
Tks5, Src and the Neural Crest
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of neural crest cells to migrate ventrally between somites towards
the yolk sac extension. Cell protrusions were not prominently seen
and appeared shorter in length. Scale bars represent 30 mm. See
Figure 3 for still images and quantification of average neural crest
cell velocity..
(AVI)
Movie S3 Neural crest cell migration in Tks5myc RNA
and Tks5 MO- co-injected Tg(sox10:RFP) embryos at 30
hpf. Z-projected time-lapse images from laser confocal microsco-
py (FV-1000, Olympus) of Tks5myc RNA and Tks5 MO co-
injected Tg(sox10:RFP) embryos at 30 hpf for 1.5 hours (1 frame/
10 min) showed ventral migration of neural crest cells between
somites towards the yolk sac extension similar to control-injected
embryos (Movie S1). Scale bars represent 30 mm. See Figure 3 for
quantification of average neural crest cell velocity.
(AVI)
Movie S4 Reduced neural crest cell migration in
Tks5FF RNA and Tks5 MO-co-injected Tg(sox10:RFP)
embryos at 30 hpf. Z-projected time-lapse images from laser
confocal microscopy (FV-1000, Olympus) of Tks5FF RNA and
Tks5 MO-co-injected Tg(sox10:RFP) embryos at 30 hpf for
1.3 hours (1 frame/10 min) showed a decreased ability of neural
crest cells to migrate ventrally between somites towards the yolk
sac extension. Cell protrusions were not prominently seen and
appeared shorter in length. Scale bars represent 30 mm. See
Figure 3 for quantification of average neural crest cell velocity.
(AVI)
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